Company has not entered any Related Party Transactions during the half year ended 31st March, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bacil Pharma Ltd has submitted a regulatory compliance filing under SEBI Regulation 23(9) stating that the company had zero Related Party Transactions during the half year ending 31st March 2026. This is a mandatory disclosure requirement under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Ms. Chaitali Kalpataru Shah, Director & CFO, and dated 22nd May 2026. The company submitted a Nil disclosure in the prescribed format, indicating no transactions occurred with related parties such as promoters, directors, key management personnel, or their relatives during the period.
This is a routine compliance filing and carries no direct impact on the stock price. A nil related party transaction disclosure is generally viewed positively from a corporate governance perspective as it indicates no potential conflicts of interest.